Part Number: NDC00074-2587-02 | Manufacturer: Abbott Laboratories Inc | NSN: 6505-01-280-1074 (6505012801074) | |
Item Name : Midazolam Hydrochlo | CAGE Code: 60060 | ||
Alternate P/N : NDC00074258702 | |||
2665 | 04-27-2024 |
We are pleased to inform you that part number NDC00074-2587-02 is currently in stock. To receive a quote, please fill out the form below with all necessary information. This part number NDC00074-2587-02, with NSN 6505012801074, is manufactured by Abbott Laboratories Inc. We will respond to your quote request within just 15 minutes.
“*” Symbols for mandatory fields
An experienced and dedicated sale representative will contact you within 15 minutes with a quote. For any other questions related to Part NDC00074-2587-02, or to expedite your response, please feel free to call us at +1 (714) 705-4780, or email your Bill of Materials (BOM) to sales@veritableaviation.com. We are here to help 24/7, 365 days a year.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-280-1074 Item Description: Midazolam Hydrochlo | 6505 | 012801074 | M | Y | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
Q | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ndc00074-2587-02 | 5 | 2 | 5 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.00 MILLIGRAMS MIDAZOLAM EQUIVALENT PER MILLILITER |
CBBL | FEATURES PROVIDED | STERILE |
CQCT | PRIMARY CONTAINER TYPE | VIAL |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
CRYC | III CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
CSGS | ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | MIDAZOLAM HYDROCHLORIDE INJECTION 1MG EQUIV PER ML IV 2ML VIAL 10S |
Don’t forget That We Can Respond to Your Instant RFQ Within Fifteen Minutes. Simply Fill Out the Fields On This Website’S Front Page and Click “Request for Quote” and Our Account Managers Will Answer ASAP!
Request for Quote